Morningstar
•
Aug 10, 2022
Bausch Health Companies Inc.: Dropping Coverage of Bausch Health Companies
Summary
Formerly known as Valeant Pharmaceuticals, Bausch Health is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The company reports revenue in five
Upgrade to begin using premium research reports and get so much more.
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
UpgradeRelated Reports
Analyst Report: Biogen Inc.
Sep 03, 2026
•
BIIB
SRPT: Raising target price to $17.00
Sep 02, 2026
•
SRPT
RH: Raising target price to $116.00
Sep 02, 2026
•
RH
VIR: Raising target price to $12.00
Sep 02, 2026
•
VIR
COTY: Rating increased to a HOLD
Sep 02, 2026
•
COTY
